ResearcherUniversity Medical Center of the Johannes Gutenberg University MainzActive in the last 2 years
Alexandra Nguyen
Matched on ORCID iD 0009-0006-7541-420X; OpenAlex author ID A5135705556. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 3
- The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/mco2.70794↗
- The protein phosphatase-2A subunit PR130 is involved in the formation of cytotoxic protein aggregates in pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1186/s12964-024-01597-8↗
- Class 1 Histone Deacetylases and Ataxia-Telangiectasia Mutated Kinase Control the Survival of Murine Pancreatic Cancer Cells upon dNTP Depletion. Co-author DOI 10.3390/cells10102520↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Oliver Holger Krämer · 3 shared papers, 2021–2026 · strength 0.59
- Paper The protein phosphatase-2A subunit PR130 is involved in the formation of cytotoxic protein aggregates in pancreatic duc… DOI 10.1186/s12964-024-01597-8↗
- Paper The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. DOI 10.1002/mco2.70794↗
- Paper Class 1 Histone Deacetylases and Ataxia-Telangiectasia Mutated Kinase Control the Survival of Murine Pancreatic Cancer … DOI 10.3390/cells10102520↗
- Janine Murr · 3 shared papers, 2021–2026 · strength 0.59
- Paper The protein phosphatase-2A subunit PR130 is involved in the formation of cytotoxic protein aggregates in pancreatic duc… DOI 10.1186/s12964-024-01597-8↗
- Paper The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. DOI 10.1002/mco2.70794↗
- Paper Class 1 Histone Deacetylases and Ataxia-Telangiectasia Mutated Kinase Control the Survival of Murine Pancreatic Cancer … DOI 10.3390/cells10102520↗
- Günter Schneider · 2 shared papers, 2021–2026 · strength 0.35
- Christian Schneeweis · 1 shared paper, 2026 · strength 0.19
- Michael B. Ghadimi · 1 shared paper, 2026 · strength 0.19
- Marian Grade · 1 shared paper, 2026 · strength 0.19
- Felix Orben · 1 shared paper, 2026 · strength 0.19
- Ulrich Bernd Keller · 1 shared paper, 2026 · strength 0.19
- Maximilian Reichert · 1 shared paper, 2026 · strength 0.19
- Lukas Krauß · 1 shared paper, 2026 · strength 0.19
- Constanza Tapia Contreras · 1 shared paper, 2026 · strength 0.19
- Carolin Schneider · 1 shared paper, 2026 · strength 0.19
- Hazal Köse · 1 shared paper, 2026 · strength 0.19
- Roland Michael Schmid · 1 shared paper, 2026 · strength 0.19
- Sebastian Mueller · 1 shared paper, 2026 · strength 0.19
- Roland Rad · 1 shared paper, 2026 · strength 0.19
- Elisabeth Heßmann · 1 shared paper, 2026 · strength 0.19
- Matthias Wirth · 1 shared paper, 2026 · strength 0.19
- Volker Ellenrieder · 1 shared paper, 2026 · strength 0.19
- Dieter Saur · 1 shared paper, 2026 · strength 0.19
- Yun Yen · 1 shared paper, 2021 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.